Centiva Capital LP Invests $941,000 in Azenta, Inc. (NASDAQ:AZTA)

Centiva Capital LP acquired a new stake in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 19,421 shares of the company's stock, valued at approximately $941,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in AZTA. Hantz Financial Services Inc. bought a new stake in shares of Azenta in the 2nd quarter worth $30,000. Farther Finance Advisors LLC boosted its holdings in Azenta by 20.0% during the third quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company's stock worth $74,000 after purchasing an additional 256 shares during the last quarter. Benjamin F. Edwards & Company Inc. grew its position in Azenta by 150.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company's stock worth $84,000 after purchasing an additional 955 shares in the last quarter. Net Worth Advisory Group purchased a new stake in Azenta in the 3rd quarter valued at about $205,000. Finally, Aigen Investment Management LP bought a new position in shares of Azenta during the 3rd quarter worth approximately $214,000. 99.08% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have weighed in on AZTA shares. Evercore ISI cut their price objective on Azenta from $53.00 to $50.00 and set an "in-line" rating on the stock in a research report on Tuesday, October 1st. Needham & Company LLC decreased their price objective on shares of Azenta from $69.00 to $55.00 and set a "buy" rating for the company in a report on Wednesday, November 13th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Azenta currently has an average rating of "Hold" and an average price target of $63.60.

Azenta Trading Up 1.3 %

Shares of AZTA stock traded up $0.59 on Friday, hitting $45.59. 352,481 shares of the stock were exchanged, compared to its average volume of 560,599. The firm's 50 day moving average is $44.79 and its two-hundred day moving average is $49.76. Azenta, Inc. has a one year low of $38.82 and a one year high of $69.16. The firm has a market capitalization of $2.08 billion, a PE ratio of -15.15 and a beta of 1.49.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its earnings results on Tuesday, November 12th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.08. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The firm had revenue of $170.00 million during the quarter, compared to the consensus estimate of $169.66 million. During the same quarter last year, the company earned $0.13 earnings per share. The company's revenue was down 1.2% on a year-over-year basis. On average, sell-side analysts expect that Azenta, Inc. will post 0.4 earnings per share for the current year.

Insider Transactions at Azenta

In other Azenta news, Director William L. Cornog bought 12,500 shares of the firm's stock in a transaction on Monday, November 18th. The shares were acquired at an average cost of $39.60 per share, for a total transaction of $495,000.00. Following the purchase, the director now directly owns 14,755 shares of the company's stock, valued at $584,298. The trade was a 554.32 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Herman Cueto sold 1,595 shares of the company's stock in a transaction that occurred on Thursday, October 17th. The stock was sold at an average price of $43.68, for a total transaction of $69,669.60. Following the completion of the transaction, the chief financial officer now owns 24,604 shares in the company, valued at approximately $1,074,702.72. This trade represents a 6.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 3,018 shares of company stock valued at $126,689. 1.77% of the stock is currently owned by corporate insiders.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.